NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | ![]() BenevolentAI BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences. | |
Founding Date | Founding Date 2011 | Founding Date 2013 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Gaithersburg, US HQ | Locations London, GB HQ Babraham, GB |
Employees | Employees 5032% decrease | Employees 180 |
Valuation ($) | Valuation ($) 372.4 k | Valuation ($) 1 b |
Financial | ||
Net income | Net income ($32.3m) (FY, 2023) | Net income (€63.3m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 33.8m | Total funding raised $ 305m |

BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences.
View company